3D Cardiac Mapping Systems Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The 3D Cardiac Mapping Systems Market Report is Segmented by Technology (Electroanatomical Mapping, Basket Catheter Mapping, and Real-Time Positional Management), End User (Hospitals, Clinics, and Diagnostic Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The Report Offers Market Size and Forecast for all the Above Segments in Value (USD).

3D Cardiac Mapping Systems Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

3D Cardiac Mapping Systems Market Size

3D Cardiac Mapping Systems Market Summary
Study Period 2021 - 2030
Market Size (2025) USD 0.60 Billion
Market Size (2030) USD 1.03 Billion
CAGR (2025 - 2030) 11.40 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

3D Cardiac Mapping Systems Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of 3D Cardiac Mapping Systems Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

3D Cardiac Mapping Systems Market Analysis

The 3D Cardiac Mapping Systems Market size is estimated at USD 0.60 billion in 2025, and is expected to reach USD 1.03 billion by 2030, at a CAGR of 11.4% during the forecast period (2025-2030).

The major factors driving the market are the rising prevalence of cardiovascular diseases coupled with the rising geriatric population, the increasing technological advancements, and growing government organizations' initiatives to create awareness about cardiovascular diseases.

The rising prevalence of cardiovascular diseases coupled with the rising geriatric population is expected to drive demand for the 3D cardiac mapping system to diagnose cardiovascular diseases such as tachyarrhythmias and atrial fibrillation, which is expected to drive the market during the forecast period. For instance, according to an article published in the Lancet in February 2024, atrial fibrillation (AF) was more prevalent, with a lifetime risk of about 1 in 3-5 individuals after the age of 45 years. Projection studies reported that the prevalence of AF is expected to rise to 15.9 million in 2050 in America and 17.9 million in 2060 in Europe.

Similarly, according to StatPearls updated data from July 2023, ventricular tachycardia is strongly associated with coronary artery disease; around 15% of patients with coronary artery disease have ventricular tachycardia. Hence, the significant prevalence of cardiovascular diseases is expected to drive the market's growth during the forecast period.

The increasing technological advancements in 3D cardiac mapping systems are expected to increase the adoption of this system for diagnosing various diseases, which will ultimately drive the growth of the market during the forecast period. For instance, according to an article published in the Frontiers in April 2023, fluoroscopy integrated 3D mapping. A new 3D non-fluoroscopic navigation system software (CARTO Univu Module) was integrated into the 3D mapping systems to reduce radiation exposure during radiofrequency catheter ablation (RFCA). Hence, such incorporation of navigation software in cardiac mapping systems is expected to drive the growth of the market during the forecast period.

Also, according to an article published in October 2022, 3D nuclear imaging was integrated into the 3D mapping system to identify low-voltage proarrhythmic areas for catheter ablation of scar-mediated ventricular tachycardia (VT). Hence, such technological advancements are expected to drive the market during the forecast period.

Thus, the above-mentioned factors, including the rising prevalence of cardiovascular diseases and increasing technological advancements in 3D mapping systems, are expected to drive the growth of the market during the forecast period. However, the high cost of 3D cardiac mapping systems is expected to restrain the market during the forecast period.

3D Cardiac Mapping Systems Industry Overview

The 3D cardiac mapping systems market is fragmented due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of several international and local companies that hold market shares and are well known, including Olympus Corporation, Medtronic, GE Healthcare, Siemens Healthiness AG, and Smith + Nephew. Abbott, Intuitive Surgical Inc., Koninklijke Philips NV, Stryker, and Zimmer Biomet.

3D Cardiac Mapping Systems Market Leaders

  1. Koninklijke Philips NV

  2. Zimmer Biomet

  3. Medtronic

  4. Smith + Nephew

  5. Stryker

  6. *Disclaimer: Major Players sorted in no particular order
3D Cardiac Mapping Systems Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

3D Cardiac Mapping Systems Market News

  • May 2024: Biosense Webster Inc., a cardiac arrhythmia treatment devices provider and part of Johnson & Johnson MedTech, launched the CARTO 3 System Version 8, the latest version of the company’s leading three-dimension (3D) heart mapping system used in cardiac ablation procedures.
  • March 2023: Medtronic received a CE (Conformité Européenne) Mark for the Affer Mapping and Ablation System, including the Sphere-9 Catheter and the Affera Prism-1 Mapping Software.

3D Cardiac Mapping Systems Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and market definitions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Cardiovascular Diseases Coupled with the Rising Geriatric Population
    • 4.2.2 Increasing Number of Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost of 3D Cardiac Mapping Systems
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Technology
    • 5.1.1 Electroanatomical Mapping
    • 5.1.2 Basket Catheter Mapping
    • 5.1.3 Real-time Positional Management
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Clinics
    • 5.2.3 Diagnostic Centers
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Olympus Corporation
    • 6.1.2 Medtronic
    • 6.1.3 GE Healthcare
    • 6.1.4 Siemens Healthineers AG
    • 6.1.5 Smith + Nephew
    • 6.1.6 Abbott
    • 6.1.7 Intuitive Surgical Inc.
    • 6.1.8 Koninklijke Philips NV
    • 6.1.9 Stryker Corporation
    • 6.1.10 Zimmer Biomet
  • *List Not Exhaustive
**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

3D Cardiac Mapping Systems Industry Segmentation

As per the scope of the report, 3D cardiac mapping system devices use mapping catheters to measure the electrical activity of cardiac tissue and create comprehensive three-dimensional electroanatomic mapping of your patients’ hearts. The 3D cardiac mapping system market is segmented into technology, end user, and geography. By technology, the market is segmented into electroanatomical mapping, basket catheter mapping, and real-time positional management. By end user, the market is segmented into hospitals, clinics, and diagnostic centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. For each segment, the market sizing and forecasts are done based on value (in USD).

By Technology Electroanatomical Mapping
Basket Catheter Mapping
Real-time Positional Management
By End User Hospitals
Clinics
Diagnostic Centers
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

3D Cardiac Mapping Systems Market Research FAQs

How big is the 3D Cardiac Mapping Systems Market?

The 3D Cardiac Mapping Systems Market size is expected to reach USD 0.60 billion in 2025 and grow at a CAGR of 11.40% to reach USD 1.03 billion by 2030.

What is the current 3D Cardiac Mapping Systems Market size?

In 2025, the 3D Cardiac Mapping Systems Market size is expected to reach USD 0.60 billion.

Who are the key players in 3D Cardiac Mapping Systems Market?

Koninklijke Philips NV, Zimmer Biomet, Medtronic, Smith + Nephew and Stryker are the major companies operating in the 3D Cardiac Mapping Systems Market.

Which is the fastest growing region in 3D Cardiac Mapping Systems Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in 3D Cardiac Mapping Systems Market?

In 2025, the North America accounts for the largest market share in 3D Cardiac Mapping Systems Market.

What years does this 3D Cardiac Mapping Systems Market cover, and what was the market size in 2024?

In 2024, the 3D Cardiac Mapping Systems Market size was estimated at USD 0.53 billion. The report covers the 3D Cardiac Mapping Systems Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the 3D Cardiac Mapping Systems Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

3D Cardiac Mapping Systems Industry Report

Statistics for the 2025 3D Cardiac Mapping Systems market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. 3D Cardiac Mapping Systems analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

3D Cardiac Mapping Systems Market Report Snapshots